SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, Paulina González-Latapí, David Davila Ortíz de Montellano, Petra Yescas, Elisa Alonso-Vilatela, Relación entre el polimorfismo DRD2/ANKK1 y el desarrollo de complicaciones motoras en enfermedad de Parkinson, Neurología Argentina, 2015, 7, 1, 28

    CrossRef

  2. 2
    Sarah Marrinan, Anton V. Emmanuel, David J. Burn, Delayed gastric emptying in Parkinson's disease, Movement Disorders, 2014, 29, 1
  3. 3
    Artur F Schumacher-Schuh, Carlos RM Rieder, Mara H Hutz, Parkinson's disease pharmacogenomics: new findings and perspectives, Pharmacogenomics, 2014, 15, 9, 1253

    CrossRef

  4. 4
    L. A. Korobeynikova, O. I. Rudko, Yu. E. Azimova, N. M. Fokina, E. A. Klimov, Genetic basis of predisposition to panic disorder, Biology Bulletin Reviews, 2012, 2, 4, 294

    CrossRef

  5. 5
    Ivette Toirac, Julio Sanju??n, Eduardo J. Aguilar, Jose C. Gonz??lez, Francesc Artigas, Olga Rivero, Carmen N??jera, Maria D. Molt??, Rosa de Frutos, Association between CCK-AR gene and schizophrenia with auditory hallucinations, Psychiatric Genetics, 2007, 17, 2, 47

    CrossRef

  6. 6
    Maurits EL Arbouw, Jeroen PP van Vugt, Toine CG Egberts, Henk-Jan Guchelaar, Pharmacogenetics of antiparkinsonian drug treatment: a systematic review, Pharmacogenomics, 2007, 8, 2, 159

    CrossRef

  7. 7
    Lisa Skipper, Jian-Jun Liu, Eng-King Tan, Polymorphisms in candidate genes: implications for the current treatment of Parkinson’s disease, Expert Opinion on Pharmacotherapy, 2006, 7, 7, 849

    CrossRef

  8. 8
    Shoko Shindo, Naofumi Yoshioka, Polymorphisms of the cholecystokinin gene promoter region in suicide victims in Japan, Forensic Science International, 2005, 150, 1, 85

    CrossRef

  9. 9
    Rosario Herranz, Cholecystokinin antagonists: Pharmacological and therapeutic potential, Medicinal Research Reviews, 2003, 23, 5
  10. 10
    Jian Wang, Yan-Mei Si, Zhuo-Lin Liu, Long Yu, Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease, Pharmacogenetics, 2003, 13, 6, 365

    CrossRef

  11. 11
    Mitsuru Ebihara, Hisako Ohba, Eiji Hattori, Kazuo Yamada, Takeo Yoshikawa, Transcriptional activities of cholecystokinin promoter haplotypes and their relevance to panic disorder susceptibility, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2003, 118B, 1